Swertiamarin
目录号: A12128
HMG-CoA reductase 抑制剂
Swertiamarin 在高胆固醇喂养的大鼠中通过抑制 HMG-CoA reductase 活性显示出作为抗动脉粥样硬化剂的潜力。
Discription | Swertiamarin has shown potential as antiatherogenic agent by inhibiting HMG-CoA reductase activity in high cholesterol fed rats. |
---|
目录号 | A12128 |
---|---|
分子式 | C16H22O10 |
分子量 | 374.34 |
CAS号 | 17388-39-5 |
SMILES | C=C[C@H]1[C@@H](OC=C2[C@]1(CCOC2=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 64 mg/mL (170.97 mM) | |
Ethanol | <1 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.71 mL | 133.57 mL | 267.14 mL |
0.5 mM | 5.34 mL | 26.71 mL | 53.43 mL |
1 mM | 2.67 mL | 13.36 mL | 26.71 mL |
5 mM | 0.53 mL | 2.67 mL | 5.34 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2